Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect

Grant

Date/time Interval

  • August 12, 2016 - September 23, 2019
  • Total Award Amount

  • 38414.00
  • Direct Costs

  • 26132.00
  • Sponsor Award Id

  • 769K753
  • Contributor

  • Anderson, Helen   Principal Investigator  
  • Boggs, Drexell   Investigator  
  • De Los Santos, Jennifer   Investigator  
  • Keene, Kimberly   Investigator  
  • Lancaster, Rachael   Investigator  
  • Parker, Catherine   Investigator  
  • Stringer-Reasor, Erica   Investigator